Literature DB >> 2918119

Contact dermatitis to transdermal estradiol system.

E I McBurney, S B Noel, J H Collins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2918119     DOI： 10.1016/s0190-9622(89)80093-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  A risk-benefit appraisal of transdermal estradiol therapy.

Authors:  A Cheang; R Sitruk-Ware; W H Utian
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 2.  Skin sensitivity and transdermal drug delivery. A review of the problem.

Authors:  A J Carmichael
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 3.  Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.

Authors:  J A Balfour; D McTavish
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

4.  Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations.

Authors:  J P Devissaguet; N Brion; O Lhote; P Deloffre
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jul-Sep       Impact factor: 2.569

Review 5.  Sex hormone allergy: clinical aspects, causes and therapeutic strategies - Update and secondary publication.

Authors:  E Untersmayr; A N Jensen; K Walch
Journal:  World Allergy Organ J       Date:  2017-12-27       Impact factor: 4.084

Review 6.  Contact dermatitis due to transdermal therapeutic systems: a clinical update.

Authors:  Paolo Romita; Caterina Foti; Gianfranco Calogiuri; Stefania Cantore; Andrea Ballini; Gianna Dipalma; Francesco Inchingolo
Journal:  Acta Biomed       Date:  2018-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.